Abstract: The invention provides an AC/DC conversion device for intelligent green-power operation and maintenance in power transmission and transformation projects, including a cabinet, an assembling panel, an inverter, a driving mechanism and a controller. A door is mounted at the front portion of the cabinet in a fixed and sealed manner, and the assembling panel is fixedly mounted on the back wall of the cabinet inside the cabinet. The assembling panel, the inverter, the driving mechanism and the controller are all provided inside the cabinet, which provides desirable dust-proof effects, preventing the case where the inverter, the driving mechanism and the controller are interfered by the dust, so that this device is suitable for outdoor usage. The driving mechanism and the controller work in coordination, so that the inverter can be switched off in time when it burns out and smokes, thereby substantially reducing the risk of fire hazards.

Abstract: The invention provides an AC/DC conversion device for intelligent green-power operation and maintenance in power transmission and transformation projects, including a cabinet, an assembling panel, an inverter, a driving mechanism and a controller. A door is mounted at the front portion of the cabinet in a fixed and sealed manner, and the assembling panel is fixedly mounted on the back wall of the cabinet inside the cabinet. The assembling panel, the inverter, the driving mechanism and the controller are all provided inside the cabinet, which provides desirable dust-proof effects, preventing the case where the inverter, the driving mechanism and the controller are interfered by the dust, so that this device is suitable for outdoor usage. The driving mechanism and the controller work in coordination, so that the inverter can be switched off in time when it burns out and smokes, thereby substantially reducing the risk of fire hazards.

Abstract: A cable includes a first part and a second part. The first part includes a cable core, a metal layer, and a dielectric layer. The metal layer wraps the cable core, and the dielectric layer is sandwiched between the cable core and the metal layer. The second part includes a plurality of metal units and a dielectric unit. The plurality of metal units are spacedly disposed on the metal layer of the cable, to reduce cable's shielding on an electromagnetic wave in a specific frequency band. The cable is placed on a radiation path of an antenna. This can reduce shielding on an electromagnetic wave radiated by the antenna, to avoid distortion of an antenna pattern.

Abstract: Methods, systems, and computer-readable media for accurate usage forecasting for virtual contact centers are disclosed. A contact center management system configures a contact center instance associated with a client. The contact center instance comprises a plurality of queues configured to store contacts. At least a portion of the contacts are routed to a plurality of agents. The contact center management system determines, using one or more machine learning models associated with the contact center instance, a plurality of predictions for a plurality of metrics for the contact center instance for a plurality of time horizons. At least a portion of the predictions are generated for individual queues of the contact center instance.

Abstract: This disclosure has presented a new loop fusion framework called DNNFusion. The key advantages of DNNFusion include: 1) a new high-level abstraction comprising mapping type of operators and their combinations and the Extended Computational Graph, and analyses on these abstractions, 2) a novel mathematical-property-based graph rewriting, and 3) an integrated fusion plan generation. DNNFusion is extensively evaluated on 15 diverse DNN models on multiple mobile devices, and evaluation results show that it outperforms four state-of-the-art DNN execution frameworks by up to 8.8× speedup, and for the first time allows many cutting-edge DNN models not supported by prior end-to-end frameworks to execute on mobile devices efficiently (even in real-time). In addition, DNNFusion improves both cache performance and device utilization, enabling execution on devices with more restricted resources. It also reduces performance tuning time during compilation.

Abstract: Provided are heteroarylquinazoline compounds represented by general formula (X), which can be used for treating cell proliferation disorders. The compounds are effective inhibitors of cyclin-dependent kinases (CDKs) and can effectively inhibit CDK2, CDK4, CDK6 and CDK9 kinases.

Abstract: The invention provides a non-naturally occurring microbial biocatalyst including a microbial organism having a 4-hydroxybutanoic acid (4-HB) biosynthetic pathway having at least one exogenous nucleic acid encoding 4-hydroxybutanoate dehydrogenase, succinyl-CoA synthetase, CoA-dependent succinic semialdehyde dehydrogenase, or ?-ketoglutarate decarboxylase, wherein the exogenous nucleic acid is expressed in sufficient amounts to produce monomeric 4-hydroxybutanoic acid (4-HB).

Abstract: BPDNN is a general end-to-end framework to achieve real-time DNN execution on mobile devices. BPDNN supports both CNNs and RNNs. It is based on a novel, fine-grained structured BCR pruning to obtain high execution efficiency without compromising accuracy. BPDNN has two main stages: a compiler-based stage to generate optimized execution codes by leveraging BCR pruning information, and an optimization framework to determine the block size and other hyperparameters based on a decoupling strategy.

Abstract: A recurrent neural network (RNN) acceleration framework leverages both a block-based pruning approach and compiler optimizations to accelerate RNN inference on mobile devices.

Abstract: The invention provides non-naturally occurring microbial organisms comprising a 1,4-butanediol (BDO), 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine pathway comprising at least one exogenous nucleic acid encoding a BDO, 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine pathway enzyme expressed in a sufficient amount to produce BDO, 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine and further optimized for expression of BDO. The invention additionally provides methods of using such microbial organisms to produce BDO, 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine.

Abstract: This disclosure has presented a new loop fusion framework called DNNFusion. The key advantages of DNNFusion include: 1) a new high-level abstraction comprising mapping type of operators and their combinations and the Extended Computational Graph, and analyses on these abstractions, 2) a novel mathematical-property-based graph rewriting, and 3) an integrated fusion plan generation. DNNFusion is extensively evaluated on 15 diverse DNN models on multiple mobile devices, and evaluation results show that it outperforms four state-of-the-art DNN execution frameworks by up to 8.8× speedup, and for the first time allows many cutting-edge DNN models not supported by prior end-to-end frameworks to execute on mobile devices efficiently (even in real-time). In addition, DNNFusion improves both cache performance and device utilization, enabling execution on devices with more restricted resources. It also reduces performance tuning time during compilation.

Abstract: Isoxazolo[5,4-H]quinazoline compounds represented by general formula (I), which can be used to treat cell proliferation disorders, and are effective cyclin-dependent kinase (CDK) inhibitors.

Abstract: The invention provides non-naturally occurring microbial organisms comprising a 1,4-butanediol (BDO) pathway comprising at least one exogenous nucleic acid encoding a BDO pathway enzyme expressed in a sufficient amount to produce BDO and further optimized for expression of BDO. The invention additionally provides methods of using such microbial organisms to produce BDO.

Abstract: The invention provides a non-naturally occurring microbial biocatalyst including a microbial organism having a 4-hydroxybutanoic acid (4-HB) biosynthetic pathway having at least one exogenous nucleic acid encoding 4-hydroxybutanoate dehydrogenase, succinyl-CoA synthetase, CoA-dependent succinic semialdehyde dehydrogenase, or ?-ketoglutarate decarboxylase, wherein the exogenous nucleic acid is expressed in sufficient amounts to produce monomeric 4-hydroxybutanoic acid (4-HB).

Abstract: An object tracking method includes: obtaining at least one image acquired by at least one image acquisition device; obtaining a first appearance feature of a target object and a first spatial-temporal feature of the target object based on the at least one image; obtaining an appearance similarity and a spatial-temporal similarity between the target object and each global tracking object in a currently recorded global tracking object queue; based on determining that the target object matches a target global tracking object based on the appearance similarity and the spatial-temporal similarity, allocating a target global identifier corresponding to the target global tracking object to the target object; determining, using the target global identifier, a plurality of associated images acquired by a plurality of image acquisition devices associated with the target object; and generating, based on the plurality of associated images, a tracking trajectory matching the target object.

Abstract: PatDNN is an end-to-end framework to achieve real-time DNN execution on mobile devices. PatDNN includes two stages: a pattern-based pruning stage based on extended ADMM solution framework, and an optimized execution code generation stage including a high-level, fine-grained DNN layerwise representation and a set of architecture-aware optimizations. This design allows PatDNN to benefit from both high accuracy and hardware efficiency.

Abstract: The invention provides non-naturally occurring microbial organisms comprising 1,4-butanediol (14-BDO) and gamma-butyrolactone (GBL) pathways comprising at least one exogenous nucleic acid encoding a 14-BDO and GBL pathway enzyme expressed in a sufficient amount to produce 14-BDO and GBL. The invention additionally provides methods of using such microbial organisms to produce 14-BDO and GBL.

Abstract: The invention provides non-naturally occurring microbial organisms comprising a 1,4-butanediol (BDO) pathway comprising at least one exogenous nucleic acid encoding a BDO pathway enzyme expressed in a sufficient amount to produce BDO and further optimized for expression of BDO. The invention additionally provides methods of using such microbial organisms to produce BDO.

Abstract: The invention provides non-naturally occurring microbial organisms comprising 1,4-butanediol (14-BDO) and gamma-butyrolactone (GBL) pathways comprising at least one exogenous nucleic acid encoding a 14-BDO and GBL pathway enzyme expressed in a sufficient amount to produce 14-BDO and GBL. The invention additionally provides methods of using such microbial organisms to produce 14-BDO and GBL.

Abstract: The invention provides non-naturally occurring microbial organisms comprising a 1,4-butanediol (BDO), 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine pathway comprising at least one exogenous nucleic acid encoding a BDO, 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine pathway enzyme expressed in a sufficient amount to produce BDO, 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine and further optimized for expression of BDO. The invention additionally provides methods of using such microbial organisms to produce BDO, 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine.